Charles Schwab Investment Management Inc Krystal Biotech, Inc. Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 250,514 shares of KRYS stock, worth $30.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
250,514
Previous 243,170
3.02%
Holding current value
$30.9 Million
Previous $38.1 Million
18.56%
% of portfolio
0.01%
Previous 0.01%
Shares
24 transactions
Others Institutions Holding KRYS
# of Institutions
328Shares Held
24.3MCall Options Held
299KPut Options Held
97.6K-
Black Rock Inc. New York, NY3.95MShares$487 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.83MShares$349 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.73MShares$337 Million7.97% of portfolio
-
State Street Corp Boston, MA1.23MShares$151 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA954KShares$118 Million0.03% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $3.17B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...